HIV care delivery has always had an ethos in it of really being based on a team-based approach, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
HIV care delivery has always had an ethos in it of really being based on a team-based approach, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Transcript
With the shift toward value-based care and emphasis being placed on care coordination, are you seeing a positive impact on patients with HIV?
Yes. I would say that in the HVI world, we kind of had it figured out, and part of the reason why HIV, I think, is a wonderful beginning model for population health management—beginning I mean we were doing this 20 years ago in HIV delivery—is because patients were so sick and were struggling so much to get based services that HIV care always demanded a team-based approach. So, in order, for example, to get you patients back in the clinic, your medical assistants who might live in the neighborhood would reach out to the patient, for example, or whatever it took. HIV, I think, has always had an ethos in it of really being based on a team-based approach, and I think it’s only now that we’re seeing, as we’re using the language of team-based approach to manage other chronic illnesses, it’s only now that we’re seeing in the HIV world that we’ve already been doing this, and how do we pull it together as something we can then talk about to other folks.
One example of how we do team-based care at my practice and how they’ve always done it, is we have these huddles at least once a week, sometimes many times, and we’ll talk about all of the patients we’re worried about. When I say we, I don’t just mean me as a provider. I also mean if the front desk staff say a patient come in for routine labs, and that patient looked more disheveled than normal, or just didn’t seem themselves, the front desk staff will bring that patient up in our care team meetings and will say, “Hey guys, I saw Mr. X and he didn’t seem well. Can someone outreach and see what’s happening?” All members of our care team feel like we own our patients together, and that’s how it’s always run.
I think one of the wonderful things now in really thinking about population health delivery and team-based care being a really important part of proactive panel management, I think in HIV care, we’re just figuring out how we translate what we’ve always done into the language that’s being used now and help our colleagues in primary care, in chronic disease management, figure out how to do some of the work we’ve had.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More